Retrieve available abstracts of 260 articles: HTML format
Single Articles
June 2025
MONTEITH TS, Lazaridou A, Bernstein C Combination behavioral and pharmacological interventions through telehealth
platforms: Opportunities for increasing access and optimizing migraine outcomes.
Headache. 2025 Jun 19. doi: 10.1111/head.14993. PubMed
BIRINGER RG Regulation of Na(+), K(+)-ATPase by cardiotonic steroids: Participation in the
sodium theory for migraine.
Headache. 2025 Jun 18. doi: 10.1111/head.14980. PubMedAbstract available
FOX J, Gaul C, Kuhlencord M, Peperkorn N, et al Identifying cognitive-affective mechanisms underlying disability in episodic
migraine: Using the fear avoidance model to examine interactions.
Headache. 2025 Jun 17. doi: 10.1111/head.14988. PubMedAbstract available
BRACA S, Russo CV, Stornaiuolo A, Cretella G, et al Effectiveness and tolerability of liraglutide as add-on treatment in patients
with obesity and high-frequency or chronic migraine: A prospective pilot study.
Headache. 2025 Jun 17. doi: 10.1111/head.14991. PubMedAbstract available
LIAO CC, Lee CI, Huang YC, Liao KR, et al Causal associations between genetically predicted placental weight and migraine.
Headache. 2025 Jun 11. doi: 10.1111/head.14977. PubMedAbstract available
COHEN F, Brooks CV, Sun D, Buse DC, et al What a long strange trip it's been: Reflections on serial snapshots of migraine
prevalence and burden in the United States.
Headache. 2025 Jun 5. doi: 10.1111/head.14984. PubMed
GETZ M, Charleston L 4th, Armand CE, Willis AW, et al Perceived discrimination and migraine-specific quality of life: A cross-sectional
survey study in a Black/African American sample.
Headache. 2025 Jun 2. doi: 10.1111/head.14970. PubMedAbstract available
ORAK SA, Polat M, Pak M, Cerci Kubur C, et al Can serum neuropeptide levels help diagnose pediatric migraine? A prospective
case-control study.
Headache. 2025 Jun 2. doi: 10.1111/head.14981. PubMedAbstract available
GOLDSTEIN H, Rau LM, Humberg C, Bachhausen V, et al Efficacy of an educational website on headaches in schoolchildren: A
cluster-randomized controlled trial.
Headache. 2025;65:961-972. PubMedAbstract available
May 2025
HERSHEY AD, Areberg J, Boserup LP, Lindsten A, et al Pharmacokinetics and safety of eptinezumab in children and adolescents with
migraine.
Headache. 2025 May 30. doi: 10.1111/head.14959. PubMedAbstract available
NIKITINA V, Santi Laurini G, Montanaro N, Motola D, et al Postmarketing safety of migraine prophylactic monoclonal antibodies: An
EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and
erenumab.
Headache. 2025 May 29. doi: 10.1111/head.14962. PubMedAbstract available
SEBROW L, Lipton RB, Metts CL, Mattis PJ, et al Cognition during ictal and interictal migraine phases: A pilot study using
ecological momentary assessment.
Headache. 2025 May 20. doi: 10.1111/head.14964. PubMedAbstract available
YOUSAF MIK, Hussey FD, Pavitt S, Irwin S, et al Memantine as a migraine prophylactic agent in adolescents: A retrospective
analysis.
Headache. 2025 May 20. doi: 10.1111/head.14979. PubMed
JENSEN MKN, O'Connell ME, Mickleborough MJS Perceptions of health, cognition, and pain among middle-aged and older adults
with migraine: A population-based cross-sectional study examining findings from
the Canadian Longitudinal Study on Aging.
Headache. 2025 May 20. doi: 10.1111/head.14953. PubMedAbstract available
BERMAN G, Mullin K, Smith T, Mosher L, et al Long-term safety and tolerability of zavegepant 10-mg nasal spray with
concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or
other select preventive migraine medications: Results from a phase 2/3 open-label
study.
Headache. 2025 May 20. doi: 10.1111/head.14954. PubMedAbstract available
FERRAO MALHEIRO S, Dourado Sotero F, Pereira MB, Nunes Vicente B, et al Validation of a Portuguese version of the four-item Migraine Interictal Burden
Scale.
Headache. 2025 May 20. doi: 10.1111/head.14958. PubMedAbstract available
MEYDANAL YE, Senisik S, Sirin H The effect of different exercise types on migraine frequency in individuals with
migraine: A pilot study.
Headache. 2025 May 20. doi: 10.1111/head.14951. PubMedAbstract available
KUCZYNSKI AM, Kingston WS Genetic migraine disorders and the response to calcitonin gene-related peptide
antagonist treatment.
Headache. 2025 May 8. doi: 10.1111/head.14942. PubMedAbstract available
PLANCHUELO-GOMEZ A, Martin-Martin C, Guerrero AL, Garcia-Azorin D, et al Long-term evolution of white and gray matter structural properties in migraine.
Headache. 2025 May 8. doi: 10.1111/head.14949. PubMedAbstract available
TURKEL NN, Vuralli D, Bolay Belen H, Kuruoglu A, et al The association of migraine and autistic traits effects on anxiety, depression,
and headache-related disability.
Headache. 2025 May 5. doi: 10.1111/head.14945. PubMedAbstract available
DENG MG, Zhou X, Liu F, Wang K, et al Plain Language Summary Publication: Investigating the causal and genetic
relationship between migraine and Parkinson's disease.
Headache. 2025 May 5. doi: 10.1111/head.14947. PubMed
April 2025
GANTENBEIN AR, Kamm CP, Schankin CJ, Zecca C, et al Swiss Quality of Life and Health Care Impact Assessment in a Real-World
Erenumab-Treated Migraine Population: Results over 2 years.
Headache. 2025 Apr 30. doi: 10.1111/head.14943. PubMedAbstract available
HOUGAARD A Time to reconsider the association between migraine and white matter
hyperintensities?
Headache. 2025 Apr 16. doi: 10.1111/head.14940. PubMed
SHIRANE R, Cohen F Counting the cost: How migraine shapes lives and economies.
Headache. 2025 Apr 11. doi: 10.1111/head.14941. PubMed
NIU PP, Zhang R, Zhang C, Li S, et al Association between migraine and cerebral white matter hyperintensities in
middle-aged and older individuals: A cross-sectional study using the UK Biobank
cohort.
Headache. 2025 Apr 11. doi: 10.1111/head.14936. PubMedAbstract available
REIDY BL, Powers SW, King CD, Kabbouche M, et al Youth with high-frequency headaches due to migraine are more vulnerable to
non-cephalic pain complaints.
Headache. 2025;65:655-657. PubMed
DE OLIVEIRA AB, Peres MFP, Mercante JPP, Brunoni AR, et al Associations of comorbid headache disorders and depression with leisure-time
physical activity among 14,088 adults in The Brazilian Longitudinal Study of
Adult Health.
Headache. 2025;65:643-654. PubMedAbstract available
March 2025
LEWIS JC, Orlova Y, Tietjen GE, Chiang CC, et al Migraine and spontaneous coronary artery dissection: A retrospective case-control
study.
Headache. 2025 Mar 28. doi: 10.1111/head.14935. PubMedAbstract available
RIMMELE F, Teuber J, Muller B, Giesen S, et al Afterimage duration differs for migraine with or without aura.
Headache. 2025 Mar 28. doi: 10.1111/head.14934. PubMedAbstract available
LOPEZ-BRAVO A, Minguez-Olaondo A, Nieves-Castellanos C, Ruibal-Salgado M, et al Patient satisfaction with calcitonin gene-related peptide monoclonal antibodies
in migraine: A multicenter prospective cohort study.
Headache. 2025 Mar 26. doi: 10.1111/head.14913. PubMedAbstract available
NAIK VV, Uniyal R, Garg RK, Verma R, et al Impact of perilesional edema on severity of migraine in patients with calcified
neurocysticercosis: A prospective evaluation.
Headache. 2025 Mar 24. doi: 10.1111/head.14929. PubMedAbstract available
VGONTZAS A, Mittleman MA, Castro-Diehl C, Isasi CR, et al Migraine and sleep apnea, insomnia, and sleep patterns in the Hispanic Community
Health Study/Study of Latinos (HCHS/SOL).
Headache. 2025 Mar 19. doi: 10.1111/head.14926. PubMedAbstract available
CHARLES AC, Goadsby PJ The cortical spreading depression/migraine aura hypothesis - Finally some
definitive evidence.
Headache. 2025 Mar 19. doi: 10.1111/head.14932. PubMed
BUSE DC, Muenzel EJ, Zagar AJ, Mehrabadi AS, et al Rates and risk factors for migraine progression using multiple definitions of
progression: Results of the longitudinal OVERCOME (US) study.
Headache. 2025 Mar 14. doi: 10.1111/head.14925. PubMedAbstract available
MAKITA LM, de Kleimmann RF, de Oliveira RR, Neves HAF, et al Assessing blood pressure changes and hypertension-related outcomes in patients
with migraine treated with erenumab: A systematic review and meta-analysis.
Headache. 2025 Mar 14. doi: 10.1111/head.14921. PubMedAbstract available
SUAREZ-BARCENA PD, Parra-Perez AM, Martin-Lagos J, Gallego-Martinez A, et al Machine learning models and classification algorithms in the diagnosis of
vestibular migraine: A systematic review and meta-analysis.
Headache. 2025 Mar 13. doi: 10.1111/head.14924. PubMedAbstract available
MCLEOD GA, Josephson CB, Engbers JDT, Cooke LJ, et al Mapping the migraine: Intracranial recording of cortical spreading depression in
migraine with aura.
Headache. 2025 Mar 8. doi: 10.1111/head.14907. PubMedAbstract available
OURO A, Castro-Mosquera M, Rodriguez-Arrizabalaga M, Debasa-Mouce M, et al Serum levels of autotaxin reveal its role as a novel biomarker of migraine.
Headache. 2025 Mar 4. doi: 10.1111/head.14922. PubMedAbstract available
DODICK DW, Tepper SJ, Ailani J, Khodavirdi AC, et al Effect of erenumab versus other migraine preventive medications on cardiovascular
and cerebrovascular outcomes: A United States claims database-based observational
cohort study.
Headache. 2025 Mar 3. doi: 10.1111/head.14912. PubMedAbstract available
LIPTON RB, Kollins JA, Albrecht D Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and
nausea-A narrative review.
Headache. 2025;65:527-535. PubMedAbstract available
February 2025
DE SANTIS F, Foschi M, Romoli M, Mastrangelo V, et al Do antithrombotic drugs have a role in migraine prevention? A systematic review.
Headache. 2025 Feb 24. doi: 10.1111/head.14917. PubMedAbstract available
TREADWELL JR, Tsou AY, Rouse B, Ivlev I, et al Behavioral interventions for migraine prevention: A systematic review and
meta-analysis.
Headache. 2025 Feb 19. doi: 10.1111/head.14914. PubMedAbstract available
JEONG E, Mogos MF, Chen Y Association of migraine treatments with reduced ischemic stroke risk: Evidence
from two large-scale real-world data analyses.
Headache. 2025 Feb 14. doi: 10.1111/head.14918. PubMedAbstract available
YEH JT, Wang YF, Tzeng YS, Chen SP, et al Exploring the impact of acute SARS-CoV-2 infection on headache pattern in
patients with migraine: A novel Bayesian analysis.
Headache. 2025 Feb 10. doi: 10.1111/head.14911. PubMedAbstract available
CHEN TY, Hsieh TY, Wang YH, Chang R, et al Association between obstructive sleep apnea and migraine: A United States
population-based cohort study.
Headache. 2025 Feb 10. doi: 10.1111/head.14904. PubMedAbstract available
SMIRNOFF L, Moskatel LS Dyspareunia and pelvic pain in women with chronic migraine: A retrospective,
observational analysis.
Headache. 2025 Feb 4. doi: 10.1111/head.14905. PubMedAbstract available
ROMOZZI M, Munafo A, Burgalassi A, De Cesaris F, et al Pharmacological differences and switching among anti-CGRP monoclonal antibodies:
A narrative review.
Headache. 2025;65:342-352. PubMedAbstract available
MANGOLD KI, Katta T, Do V, Moore RD, et al White matter hyperintensities and headache in United States military veterans
with mild traumatic brain injury.
Headache. 2025;65:206-215. PubMedAbstract available
January 2025
KUAN AS, Wang YF, Chen SP, Chuang YF, et al Sex differences in pain, suicidal ideation, and suicide attempts in patients with
migraine.
Headache. 2025 Jan 24. doi: 10.1111/head.14906. PubMedAbstract available
SENG EK, Muenzel EJ, Shapiro RE, Buse DC, et al Development of the Migraine-Related Stigma (MiRS) Questionnaire: Results of the
OVERCOME (US) Study.
Headache. 2025 Jan 22. doi: 10.1111/head.14886. PubMedAbstract available
SILVESTRI G, Roccatagliata L, Tazza F, Schiavi S, et al The "central vein sign" to differentiate multiple sclerosis from migraine.
Headache. 2025 Jan 20. doi: 10.1111/head.14902. PubMedAbstract available
HARO M, Garate G, Hernandez JL, Olmos JM, et al Low serum 25-hydroxyvitamin D levels in migraine are not related to headache
frequency: A case-control study in patients with high-frequency/chronic migraine.
Headache. 2025 Jan 13. doi: 10.1111/head.14901. PubMedAbstract available
MINEN MT, Whetten C, Messier D, Mehta S, et al Headache diagnosis and treatment: A pilot knowledge and needs assessment among
physical therapists.
Headache. 2025;65:90-100. PubMedAbstract available
RIVA E, Kurtis MM, Valls A, Franch O, et al Beyond movement: Headache in patients with functional movement disorders.
Headache. 2025;65:197-201. PubMedAbstract available
December 2024
BLASZCZYK B, Waliszewska-Prosol M, Smardz J, Wieckiewicz M, et al Exploring the associations of sleep bruxism and obstructive sleep apnea with
migraine among patients with temporomandibular disorder: A polysomnographic
study.
Headache. 2024 Dec 30. doi: 10.1111/head.14892. PubMedAbstract available
YAN L, Huang Y, Xie B, Liu Z, et al Association of periodontitis and periodontal parameters with migraine and
mortality in people with migraine disease: A nationally representative
observational study.
Headache. 2024 Dec 30. doi: 10.1111/head.14893. PubMedAbstract available
OLSON PA, Powers SW Behavior and migraine virtual issue.
Headache. 2024 Dec 30. doi: 10.1111/head.14896. PubMed
SHARIFI A, Kouhi A, Steenerson KK, Sharon JD, et al Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) : A
narrative review.
Headache. 2024 Dec 30. doi: 10.1111/head.14866. PubMedAbstract available
JAIMES A, Gomez A, Pajares O, Rodriguez-Vico J, et al Effectiveness of switching strategies in CGRP monoclonal antibody therapy for
migraine: A retrospective cohort study.
Headache. 2024 Dec 27. doi: 10.1111/head.14865. PubMedAbstract available
SU TH, Wang JK, Kuo PH, Chang SH, et al The pathogenic role of calcitonin gene-related peptide and predictors of
new-onset migraine and long-term outcomes after transcatheter atrial septal
defect closure.
Headache. 2024 Dec 11. doi: 10.1111/head.14885. PubMedAbstract available
DENG MG, Zhou X, Liu F, Wang K, et al Investigating the causal and genetic relationship between migraine and
Parkinson's disease.
Headache. 2024 Dec 10. doi: 10.1111/head.14881. PubMedAbstract available
November 2024
HUSSEIN M, Hassan A, Nada MAF, Mohammed Z, et al Validity, reliability, and sensitivity to change of the Arabic version of the
Migraine-Specific Quality-of-Life Questionnaire after prophylactic treatment.
Headache. 2024 Nov 27. doi: 10.1111/head.14874. PubMedAbstract available
PANZA GA, Johnson MAL, Kuruvilla DE A post hoc analysis of migraine-associated symptoms from the phase 3 randomized,
double-blind, sham-controlled Trial of External trigeminal nerve stimulation for
the Acute treatment of Migraine (TEAM) study.
Headache. 2024 Nov 27. doi: 10.1111/head.14860. PubMedAbstract available
LIPTON RB, Gendolla A, Abraham L, Jenkins A, et al Relative frequency, characteristics, and disease burden of patients with migraine
unsuitable for triptan treatment: A systematic literature review.
Headache. 2024 Nov 27. doi: 10.1111/head.14854. PubMedAbstract available
AILANI J, Lipton RB, Blumenfeld AM, Mechtler L, et al Safety and tolerability of ubrogepant for the acute treatment of migraine in
participants taking atogepant for the preventive treatment of episodic migraine:
Results from the TANDEM study.
Headache. 2024 Nov 21. doi: 10.1111/head.14871. PubMedAbstract available
GOPALAKRISHNAN R, Malan NS, Mandava N, Dunn EJ, et al Magnetoencephalography studies in migraine and headache disorders: A systematic
review.
Headache. 2024 Nov 10. doi: 10.1111/head.14867. PubMedAbstract available
DAGHLAS I, Rist PM, Chasman DI Genetically proxied liability to migraine and risk of intracranial aneurysm and
subarachnoid hemorrhage.
Headache. 2024 Nov 7. doi: 10.1111/head.14851. PubMedAbstract available
BERTZ RJ, Collins JL, Madonia J, Bhardwaj R, et al Comparative bioavailability of single-dose zavegepant during and between migraine
attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study.
Headache. 2024 Nov 7. doi: 10.1111/head.14856. PubMedAbstract available
GRYGLAS-DWORAK A, Schim J, Ettrup A, Boserup LP, et al Long-term reductions in acute headache medication use after eptinezumab treatment
in patients with migraine and prior preventive treatment failures: Post hoc
analysis of the DELIVER randomized trial.
Headache. 2024 Nov 5. doi: 10.1111/head.14862. PubMedAbstract available
SHEWALE AR, Poh W, Reed ML, Liu J, et al Ubrogepant users' real-world experience: Patients on ubrogepant, characteristics
and outcomes (UNIVERSE) study.
Headache. 2024;64:1244-1252. PubMedAbstract available
CASCELLA RH, Anderson CC, Perez EJ The impact of updates in headache quality measures on adherence to best practices
in a neurology resident clinic: A quality improvement study.
Headache. 2024;64:1329-1335. PubMedAbstract available
October 2024
PATTERSON GENTILE C, Szperka CL, Hershey AD Cluster Analysis of Migraine-associated Symptoms (CAMS) in youth: A retrospective
cross-sectional multicenter study.
Headache. 2024 Oct 27. doi: 10.1111/head.14859. PubMedAbstract available
PATTERSON GENTILE C, Hershey AD, Szperka CL A critical appraisal of the International Classification of Headache Disorders
migraine diagnostic criteria based on a retrospective multicenter cross-sectional
headache registry study in youth.
Headache. 2024 Oct 27. doi: 10.1111/head.14858. PubMedAbstract available
COHEN F, Brooks CV, Sun D, Buse DC, et al Challenges and opportunities for estimating and assessing migraine prevalence,
incidence and impact across study populations and methodologies: Bridging global
and United States findings.
Headache. 2024 Oct 23. doi: 10.1111/head.14864. PubMed
TAVASOLI AR, Rastogi RG, Hastriter EV Rising migraine incidence in adolescents despite stable prevalence in the US: A
call for further investigation.
Headache. 2024 Oct 19. doi: 10.1111/head.14844. PubMed
SENG EK, Hill J, Reeder AK, Visvanathan P, et al Feasibility, acceptability, and fidelity of remote-delivered abbreviated
mindfulness-based cognitive therapy interventions for patients with migraine and
depressive symptoms.
Headache. 2024 Oct 14. doi: 10.1111/head.14857. PubMedAbstract available
RUIZ-TAGLE A, Caetano G, Fouto A, Esteves I, et al Preserved working memory performance along with subcortical modulation during
peri-ictal phases in spontaneous migraine attacks.
Headache. 2024 Oct 13. doi: 10.1111/head.14850. PubMedAbstract available
KIRKLAND S, Meyer J, Visser L, Campbell S, et al The effectiveness of parenteral agents to mitigate relapses after severe acute
migraine headache presentations: A systematic review and network analysis.
Headache. 2024 Oct 4. doi: 10.1111/head.14841. PubMedAbstract available
BHARDWAJ R, Donohue MK, Madonia J, Matschke K, et al Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant
and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy
adults.
Headache. 2024 Oct 4. doi: 10.1111/head.14853. PubMedAbstract available
TUMMOSZEIT IZ, Olofsson IA, Chalmer MA, Henriksen AP, et al No association between migraine and HLA alleles in a cohort of 13,210 individuals
with migraine from the Danish Blood Donor Study.
Headache. 2024 Oct 1. doi: 10.1111/head.14784. PubMedAbstract available
September 2024
SOTTANI C, Di Lazzaro G, Calabresi P, Pomponi MG, et al Efficacy of galcanezumab in proline-rich transmembrane protein 2
(PRRT2)-associated familial hemiplegic migraine: A case series.
Headache. 2024 Sep 30. doi: 10.1111/head.14840. PubMedAbstract available
SHARON JD, Krauter R, Chae R, Gardi A, et al A placebo controlled, randomized clinical trial of galcanezumab for vestibular
migraine: The INVESTMENT study.
Headache. 2024 Sep 30. doi: 10.1111/head.14835. PubMedAbstract available
PEASAH SK, Soh YH, Huang Y, Nguyen J, et al Patient reported outcomes and the real-world use of calcitonin gene-related
peptide medications in migraine.
Headache. 2024 Sep 30. doi: 10.1111/head.14843. PubMedAbstract available
ORR SL, Kuziek J, Ali S, Anderson E, et al Remote electrical neuromodulation to treat children and adolescents with migraine
in the emergency department: A randomized double-dummy pilot trial.
Headache. 2024 Sep 17. doi: 10.1111/head.14838. PubMedAbstract available
SOTERO FD, Nobre J, Vicente BN, Martins IP, et al Predictors of migraine interictal burden: The hidden role of subjective memory
complaints.
Headache. 2024 Sep 13. doi: 10.1111/head.14819. PubMedAbstract available
KANG S, Eun Y, Han K, Jung J, et al Heightened migraine risk in patients with rheumatoid arthritis: A national
retrospective cohort study.
Headache. 2024 Sep 13. doi: 10.1111/head.14832. PubMedAbstract available
DE DIOS A, Pages-Puigdemont N, Ojeda S, Riera P, et al Persistence, effectiveness, and tolerability of anti-calcitonin gene-related
peptide monoclonal antibodies in patients with chronic migraine.
Headache. 2024 Sep 13. doi: 10.1111/head.14827. PubMedAbstract available
MULTANI JK, Urman R, Park AS, Gill K, et al Changes in use of acute and preventive medications for migraine after erenumab
initiation over 12 months: A United States retrospective cohort study.
Headache. 2024 Sep 9. doi: 10.1111/head.14820. PubMedAbstract available
AILANI J, Gandhi P, Lalla A, Halker Singh R, et al Cost per treatment responder analysis of atogepant compared to rimegepant for the
preventive treatment of episodic migraine.
Headache. 2024 Sep 9. doi: 10.1111/head.14824. PubMedAbstract available
MCGINLEY JS, Mangrum R, Gerstein MT, McCarrier KP, et al Symptoms across the phases of the migraine cycle from the patient's perspective:
Results of the MiCOAS qualitative study.
Headache. 2024 Sep 2. doi: 10.1111/head.14817. PubMedAbstract available
TATSUMOTO M, Ishida M, Iba K, Kim BK, et al Effects of fremanezumab on migraine-associated symptoms and medication use in
Japanese and Korean patients with episodic migraine: Exploratory endpoint
analysis of a multicenter, randomized, double-blind, placebo-controlled trial.
Headache. 2024 Sep 2. doi: 10.1111/head.14810. PubMedAbstract available
MOHAMMADNEZHAD G, Assarzadegan F, Koosha M, Esmaily H, et al Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A
randomized controlled trial.
Headache. 2024 Sep 2. doi: 10.1111/head.14808. PubMedAbstract available
MARTIN EG, Kuziek J, Rasiah J, Orr SL, et al Evaluating patient and family preferences for acute and preventive pediatric
headache treatment.
Headache. 2024;64:950-966. PubMedAbstract available
August 2024
SMITH DC, Zhang J, Jayasuriya S, Berisha V, et al The impact of headache intensity on speech in participants with migraine and
acute post-traumatic headache.
Headache. 2024 Aug 28. doi: 10.1111/head.14809. PubMedAbstract available
FUGLSANG CH, Pedersen L, Schmidt M, Vandenbroucke JP, et al The combined impact of migraine and gestational diabetes on long-term risk of
premature myocardial infarction and stroke: A population-based cohort study.
Headache. 2024 Aug 28. doi: 10.1111/head.14821. PubMedAbstract available
KIM JR, Park TJ, Agapova M, Blumenfeld A, et al Healthcare resource use and costs associated with the misdiagnosis of migraine.
Headache. 2024 Aug 28. doi: 10.1111/head.14822. PubMedAbstract available
HERBERT MS, Merritt VC, Afari N, Gasperi M, et al Cognitive symptoms in veterans with migraine or traumatic brain injury: A Million
Veteran Program study.
Headache. 2024 Aug 28. doi: 10.1111/head.14815. PubMedAbstract available
DENNEY DE, Lee AA, Landy SH, Smitherman TA, et al Plain language summary publication: Headache-related disability as a function of
migraine aura: A daily diary study.
Headache. 2024 Aug 23. doi: 10.1111/head.14811. PubMed
CHIANG CC, Schwedt TJ, Dumkrieger G, Wang L, et al Advancing toward precision migraine treatment: Predicting responses to preventive
medications with machine learning models based on patient and migraine features.
Headache. 2024 Aug 23. doi: 10.1111/head.14806. PubMedAbstract available
SHARMA TL, Lucas S, Barber J, Hoffman JM, et al Pilot study evaluating treatment with sumatriptan for moderate to severe
post-traumatic headache: A phase 2 open-label study.
Headache. 2024 Aug 13. doi: 10.1111/head.14807. PubMedAbstract available
LINDSAY R, Kalifa A, Kuziek J, Kabbouche M, et al The safety and efficacy of onabotulinumtoxinA injections for children and
adolescents with chronic migraine: A systematic review and meta-analysis.
Headache. 2024 Aug 11. doi: 10.1111/head.14798. PubMedAbstract available
DENNEY DE, Lee AA, Landy SH, Smitherman TA, et al Headache-related disability as a function of migraine aura: A daily diary study.
Headache. 2024 Aug 1. doi: 10.1111/head.14796. PubMedAbstract available
SUZUKI Y, Kiyosawa M, Wakakura M, Ishii K, et al Plain Language Summary Publication: Hyperactivity of the medial thalamus in
patients with photophobia-associated migraine.
Headache. 2024 Aug 1. doi: 10.1111/head.14792. PubMed
July 2024
DUMKRIEGER GM, Ishii R, Goadsby PJ Flexible modeling of headache frequency fluctuations in migraine with hidden
Markov models.
Headache. 2024 Jul 30. doi: 10.1111/head.14782. PubMedAbstract available
TRIVEDI M, Dumkrieger G, Chong CD, Leibovit-Reiben Z, et al A history of abuse is associated with more severe migraine- and pain-related
disability: Results from the American Registry for Migraine Research.
Headache. 2024 Jul 25. doi: 10.1111/head.14787. PubMedAbstract available
SUZUKI Y, Kiyosawa M, Wakakura M, Ishii K, et al Hyperactivity of the medial thalamus in patients with photophobia-associated
migraine.
Headache. 2024 Jul 18. doi: 10.1111/head.14785. PubMedAbstract available
BURNS KN, Zhao H, Master C, Langford D, et al Migraine epidemiology in collegiate student-athletes: Findings from the
Concussion Assessment, Research, and Education (CARE) Consortium.
Headache. 2024 Jul 18. doi: 10.1111/head.14799. PubMedAbstract available
OLOFSSON IA Migraine heritability and beyond: A scoping review of twin studies.
Headache. 2024 Jul 18. doi: 10.1111/head.14789. PubMedAbstract available
CHARLESTON L 4TH Developing and delivering a migraine disparities and diagnosis undergraduate
medical educational program to underrepresented in medicine medical student
members of the Student National Medical Association: A pilot project.
Headache. 2024 Jul 16. doi: 10.1111/head.14791. PubMedAbstract available
ORNELLO R, Baldini F, Onofri A, Rosignoli C, et al Impact of duration of chronic migraine on long-term effectiveness of monoclonal
antibodies targeting the calcitonin gene-related peptide pathway-A real-world
study.
Headache. 2024 Jul 16. doi: 10.1111/head.14788. PubMedAbstract available
MATHARU M, Katsarava Z, Buse DC, Sommer K, et al Plain Language Summary Publication: Characterizing neck pain during headache
among people with migraine: Multicountry results from the Chronic Migraine
Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
Headache. 2024 Jul 16. doi: 10.1111/head.14786. PubMed
BOUGIE JK, Krupsky K, Beusterien K, Ladouceur MP, et al Patient preferences for preventive migraine treatments among Canadian adults: A
discrete choice experiment.
Headache. 2024 Jul 9. doi: 10.1111/head.14781. PubMedAbstract available
LIPTON RB, Ailani J, Mullin K, Pavlovic JM, et al Situational prevention: Pharmacotherapy during periods of increased risk for
migraine attacks.
Headache. 2024 Jul 3. doi: 10.1111/head.14775. PubMedAbstract available
ROBBLEE J, Orlova YY, Ahn AH, Ali AS, et al Real-world approaches to outpatient treatment of status migrainosus: A survey
study.
Headache. 2024 Jul 3. doi: 10.1111/head.14769. PubMedAbstract available
SILBERSTEIN SD, Diener HC, Dodick DW, Sommer K, et al Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An
analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy
(PREEMPT) randomized controlled trials.
Headache. 2024;64:838-848. PubMedAbstract available
MATHARU M, Katsarava Z, Buse DC, Sommer K, et al Characterizing neck pain during headache among people with migraine: Multicountry
results from the Chronic Migraine Epidemiology and Outcomes - International
(CaMEO-I) cross-sectional study.
Headache. 2024;64:750-763. PubMedAbstract available
ROBBLEE J, Zhao XR, Minen MT, Friedman BW, et al Plain Language Summary Publication: The 2023 protocol for update to acute
treatment of adults with migraine in the emergency department: The American
headache society evidence assessment of parenteral pharmacotherapies.
Headache. 2024;64:901-902. PubMed
KLAN T, Brascher AK, Seng EK, Gaul C, et al German language adaptation of the Cogniphobia Scale for Headache Disorders
(CS-HD) and development of a new short form (CS-HD-6).
Headache. 2024;64:772-782. PubMedAbstract available
June 2024
ORR SL Parental mental health and migraine in youth: An evolving story historically
plagued with sparse and inadequate literature and mother-blaming.
Headache. 2024 Jun 27. doi: 10.1111/head.14779. PubMed
MARZOUK MA, Buse DC, Karvounides D, Powers SW, et al Not their fault: Mental health characteristics of parents with migraine and the
migraine status of their children.
Headache. 2024 Jun 27. doi: 10.1111/head.14773. PubMed
VURAL S, Turksoy VA, Uzun Akgeyik A, Kusdogan M, et al Heavy metal and trace element alterations in patients during a migraine attack.
Headache. 2024 Jun 27. doi: 10.1111/head.14748. PubMedAbstract available
VIVES-MESTRES M, Casanova A, Silberstein SD, Hershey AD, et al Clinical factors associated with day-to-day peak pain severity in individuals
with chronic migraine: A cohort study using daily prospective diary data.
Headache. 2024 Jun 27. doi: 10.1111/head.14745. PubMedAbstract available
BLUMENFELD A, Kudrow D, McAllister P, Boserup LP, et al Long-term effectiveness of eptinezumab in the treatment of patients with chronic
migraine and medication-overuse headache.
Headache. 2024 Jun 24. doi: 10.1111/head.14767. PubMedAbstract available
PASCUAL-MATO M, Garate G, Gonzalez-Quintanilla V, Madera-Fernandez J, et al Differences in circulating alpha-calcitonin gene-related peptide levels in
inflammatory bowel disease and its relation to migraine comorbidity: A
cross-sectional study.
Headache. 2024 Jun 24. doi: 10.1111/head.14768. PubMedAbstract available
CROPPER HC, Conway CM, Wyche W, Pradhan AA, et al Glial activation in pain and emotional processing regions in the nitroglycerin
mouse model of chronic migraine.
Headache. 2024 Jun 20. doi: 10.1111/head.14740. PubMedAbstract available
JOSHI S, Spargo A, Hoyt M, Panni T, et al A 3-year follow-up study of outcomes associated with patterns of traditional
acute and preventive migraine treatment: An administrative claims-based cohort
study in the United States.
Headache. 2024 Jun 19. doi: 10.1111/head.14741. PubMedAbstract available
NANDYALA A, Burch R, Halker Singh R Migraine in women.
Headache. 2024 Jun 14. doi: 10.1111/head.14783. PubMed
WELLS RE, O'Connell N, Minen MT Mechanisms for mindfulness in migraine: Does catastrophizing matter?
Headache. 2024 Jun 6. doi: 10.1111/head.14730. PubMed
CONTI M, Bovenzi R, Palmieri MG, Placidi F, et al Early effect of onabotulinumtoxinA on EEG-based functional connectivity in
patients with chronic migraine: A pilot study.
Headache. 2024 Jun 4. doi: 10.1111/head.14750. PubMedAbstract available
ROBBLEE J, Zhao XR, Minen MT, Friedman BW, et al The 2023 protocol for update to acute treatment of adults with migraine in the
emergency department: The American Headache Society evidence assessment of
parenteral pharmacotherapies.
Headache. 2024 Jun 3. doi: 10.1111/head.14744. PubMedAbstract available
May 2024
DAFER RM, Tietjen GE, Rothrock JF, Vann RE, et al Cardiovascular safety of dihydroergotamine mesylate delivered by precision
olfactory delivery (INP104) for the acute treatment of migraine.
Headache. 2024 May 27. doi: 10.1111/head.14669. PubMedAbstract available
SU Y, Tay VQ, Singh S, Leary MC, et al A retrospective review of sex differences of white matter hyperintensities in
brain MRI of patients with migraine.
Headache. 2024 May 24. doi: 10.1111/head.14714. PubMedAbstract available
WANG SJ, Kim BK, Wang H, Zhou J, et al Effect of erenumab on the reversion from chronic migraine to episodic migraine in
an Asian population: A post hoc analysis of the DRAGON study.
Headache. 2024 May 24. doi: 10.1111/head.14733. PubMedAbstract available
ZHAO YJ, Ong JJY, Sonu SK, Dang J, et al A real-world prospective observational study of eptinezumab in Asian patients
with migraine.
Headache. 2024 May 24. doi: 10.1111/head.14737. PubMedAbstract available
ASHINA S, Muenzel EJ, Nicholson RA, Zagar AJ, et al Machine learning identifies factors most associated with seeking medical care for
migraine: Results of the OVERCOME (US) study.
Headache. 2024 May 24. doi: 10.1111/head.14729. PubMedAbstract available
SHAO SC, Hentz J, Shank P, Leonard M, et al Functional impairment of chronic migraine with medication overuse: Secondary
analysis from the Medication Overuse Treatment Strategy (MOTS) trial.
Headache. 2024 May 23. doi: 10.1111/head.14732. PubMedAbstract available
MAY A Beyond aura: Understanding migraine as a cycling pan-sensory threshold disease.
Headache. 2024 May 23. doi: 10.1111/head.14736. PubMed
BUSE DC, Sakai F, Matharu M, Reed ML, et al Characterizing gaps in the preventive pharmacologic treatment of migraine:
Multi-country results from the CaMEO-I study.
Headache. 2024 May 5. doi: 10.1111/head.14721. PubMedAbstract available
ANDERSON CC, Iser CR, Hirte IL, Boddu S, et al Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for
the treatment of chronic migraine and other headache disorders-A retrospective
tolerability and safety study.
Headache. 2024 May 3. doi: 10.1111/head.14725. PubMedAbstract available
COHEN F, Brooks CV, Sun D, Buse DC, et al Prevalence and burden of migraine in the United States: A systematic review.
Headache. 2024 May 3. doi: 10.1111/head.14709. PubMedAbstract available
REDUCHA PV, Bomers JP, Edvinsson L, Haanes KA, et al The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain
responses: Insights from an animal model.
Headache. 2024 May 3. doi: 10.1111/head.14726. PubMedAbstract available
INCE MS, Guzel I, Akgor MC, Bahcelioglu M, et al Virtual dynamic interaction games reveal impaired multisensory integration in
women with migraine.
Headache. 2024 May 1. doi: 10.1111/head.14720. PubMedAbstract available
April 2024
XU D, Wu B Investigating the causal association between systemic lupus erythematosus and
migraine using Mendelian randomization analysis.
Headache. 2024 Apr 28. doi: 10.1111/head.14723. PubMedAbstract available
ZHU G, Wang M, Kong F Blood serum levels of PACAP and migraine onset: A systematic review and
meta-analysis of observational studies.
Headache. 2024 Apr 24. doi: 10.1111/head.14711. PubMedAbstract available
HUSSEIN M, Hassan A, Nada MAF, Mohammed Z, et al Reliability, validity, and responsiveness of the Arabic version of HIT-6
questionnaire in patients with migraine indicated for preventive therapy: A
multi-center study.
Headache. 2024 Apr 23. doi: 10.1111/head.14719. PubMedAbstract available
ERMAKOVA E, Shaidullova K, Gafurov O, Kabirova A, et al Implications of high homocysteine levels in migraine pain: An experimental study
of the excitability of peripheral meningeal afferents in rats with
hyperhomocysteinemia.
Headache. 2024 Apr 22. doi: 10.1111/head.14710. PubMedAbstract available
VYAS MV, Lee N, Lay C Association between migraine and exclusive breastfeeding: A cross-sectional
study.
Headache. 2024 Apr 21. doi: 10.1111/head.14713. PubMedAbstract available
GELFAND AA Depression and anxiety are not associated with migraine outcomes in children and
adolescents.
Headache. 2024 Apr 18. doi: 10.1111/head.14700. PubMed
ROBBLEE J, Hakim SM, Reynolds JM, Monteith TS, et al Nonspecific oral medications versus anti-calcitonin gene-related peptide
monoclonal antibodies for migraine: A systematic review and meta-analysis of
randomized controlled trials.
Headache. 2024 Apr 18. doi: 10.1111/head.14693. PubMedAbstract available
REINA-VARONA A, Madronero-Miguel B, Fierro-Marrero J, Paris-Alemany A, et al Efficacy of various exercise interventions for migraine treatment: A systematic
review and network meta-analysis.
Headache. 2024 Apr 10. doi: 10.1111/head.14696. PubMedAbstract available
RIZVI BA, Kuziek J, Cho LY, Ronksley PE, et al Anxiety and depressive symptoms and migraine-related outcomes in children and
adolescents.
Headache. 2024 Apr 6. doi: 10.1111/head.14701. PubMedAbstract available
KIRKLAND SW, Visser L, Meyer J, Junqueira DR, et al The effectiveness of parenteral agents for pain reduction in patients with
migraine presenting to emergency settings: A systematic review and network
analysis.
Headache. 2024;64:424-447. PubMedAbstract available
SEEBADRI-WHITE C, Yuan H, Young WB, Arca KN, et al Advocacy Connection Team-Now educational program for headache fellows and
patients/caregivers: Assessment of educational objectives.
Headache. 2024;64:374-379. PubMedAbstract available
March 2024
DODICK DW, Reed ML, Lee L, Balkaran BL, et al Impact of headache frequency and preventive treatment failure on quality of life,
disability, and direct and indirect costs among individuals with episodic
migraine in the United States.
Headache. 2024 Mar 24. doi: 10.1111/head.14684. PubMedAbstract available
KRIKOVA I, Digre KB, Katz BJ, Seay MD, et al Migraine, idiopathic intracranial hypertension, and calcitonin gene-related
peptide antibodies.
Headache. 2024 Mar 13. doi: 10.1111/head.14686. PubMed
CHARLES AC, Digre KB, Goadsby PJ, Robbins MS, et al Calcitonin gene-related peptide-targeting therapies are a first-line option for
the prevention of migraine: An American Headache Society position statement
update.
Headache. 2024 Mar 11. doi: 10.1111/head.14692. PubMedAbstract available
SPROUSE BLUM AS, DaSilva LA, Greenberg MD, Nissenbaum AJ, et al Comparison of migraine with left- versus right-sided headache: A cross-sectional
study.
Headache. 2024 Mar 3. doi: 10.1111/head.14689. PubMedAbstract available
HOOGEVEEN ES, Pelzer N, Ghariq E, van Osch MJP, et al Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual-echo
arterial spin labeling MRI study.
Headache. 2024 Mar 2. doi: 10.1111/head.14680. PubMedAbstract available
GIBLER RC, Knestrick KE, Powers SW, Hershey AD, et al Preliminary prospective observational investigation of clinical outcomes among
treatment-seeking youth with continuous headache.
Headache. 2024;64:319-322. PubMed
LIPTON RB, Albrecht D, Bermudez M, Hu J, et al A randomized, open-label, 5-period crossover study evaluating the
pharmacokinetics and safety of a single dose of intranasal dihydroergotamine
(DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in
healthy adults.
Headache. 2024;64:266-275. PubMedAbstract available
February 2024
SCUTELNIC A, Sutter NL, Beyeler M, Meinel TR, et al Characteristics of acute ischemic stroke and unusual aura in patients with
migraine with aura.
Headache. 2024 Feb 27. doi: 10.1111/head.14682. PubMedAbstract available
CHHABRA N, Mead-Harvey C, Dodoo CA, Iser C, et al Blood pressure elevation in erenumab-treated patients with migraine: A
retrospective real-world experience.
Headache. 2024 Feb 27. doi: 10.1111/head.14679. PubMedAbstract available
Correction to: "Once-daily oral atogepant for the long-term preventive treatment
of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial".
Headache. 2024 Feb 26. doi: 10.1111/head.14691. PubMed
ROSSIGNOL J, Ouimet T, Poras H, Dallel R, et al Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan
in a preclinical model of migraine.
Headache. 2024 Feb 22. doi: 10.1111/head.14681. PubMedAbstract available
MITTLEMAN MR, Mostofsky E, Vgontzas A, Bertisch SM, et al Habitual caffeinated beverage consumption and headaches among adults with
episodic migraine: A prospective cohort study.
Headache. 2024 Feb 6. doi: 10.1111/head.14673. PubMedAbstract available
VAN DEN HOEK TC, Verhagen IE, de Boer I, Terwindt GM, et al Substance use in a Dutch migraine cohort compared with the general population.
Headache. 2024 Feb 1. doi: 10.1111/head.14663. PubMedAbstract available
LANGDON RL, DiSabella MT, Strelzik JA Screen time and pediatric headache: A scoping review of the literature.
Headache. 2024;64:211-225. PubMedAbstract available
HAN C, Lim JY, Koike N, Kim SY, et al Regulation of headache response and transcriptomic network by the trigeminal
ganglion clock.
Headache. 2024;64:195-210. PubMedAbstract available
JICHA C, Pham K Neuromodulation for primary headache disorders: Advantages and challenges.
Headache. 2024;64:226-228. PubMed
PRADHAN SK, Gantenbein AR, Li Y, Shaban H, et al Daith piercing: Revisited from the perspective of auricular acupuncture systems.
A narrative review.
Headache. 2024;64:131-140. PubMedAbstract available
January 2024
ZHANG P, Ventrapragada A, Shapiro RE, Do TP, et al Metaphorical use of "headache" and "migraine" in media: A longitudinal study of
1.3 million articles in major publications.
Headache. 2024 Jan 18. doi: 10.1111/head.14661. PubMedAbstract available
VGONTZAS A Examining substance use patterns in adults with migraine: A changing landscape.
Headache. 2024 Jan 18. doi: 10.1111/head.14660. PubMed
MANGRUM R, Bryant AL, Gerstein MT, McCarrier KP, et al The impacts of migraine on functioning: Results from two qualitative studies of
people living with migraine.
Headache. 2024 Jan 18. doi: 10.1111/head.14664. PubMedAbstract available
PATNIYOT I, Banerjee A, Nobleza K, Nguyen D, et al A retrospective analysis of the use of candesartan for migraine prevention in
adolescents.
Headache. 2024;64:96-97. PubMed
DE OLIVEIRA FAA, Dourado-Filho MG, Sampaio Rocha-Filho PA Persistent headache attributed to past ischemic stroke: A prospective cohort
study.
Headache. 2024;64:48-54. PubMedAbstract available
December 2023
BELTRAMONE M, Redon S, Donnet A Bone site fracture pain after subcutaneous sumatriptan injection: A report of two
cases.
Headache. 2023 Dec 29. doi: 10.1111/head.14662. PubMed
RHUDY C, Schadler A, Huffmyer M, Porter L, et al Rural disparities in emergency department utilization for migraine care.
Headache. 2023 Dec 12. doi: 10.1111/head.14659. PubMedAbstract available
CHASE BA, Semenov I, Rubin S, Meyers S, et al Characteristics associated with response to subcutaneously administered anti-CGRP
monoclonal antibody medications in a real-world community cohort of persons
living with migraine: A retrospective clinical and genetic study.
Headache. 2023 Dec 10. doi: 10.1111/head.14655. PubMedAbstract available
November 2023
PODRAZA K, Bangera N, Feliz A, Charles A, et al Reduction in retinal microvascular perfusion during migraine attacks.
Headache. 2023 Nov 30. doi: 10.1111/head.14654. PubMedAbstract available
MACGREGOR EA, Okonkwo R, Detke HC, Polavieja P, et al Effect of galcanezumab in women with episodic migraine meeting criteria for
menstrually related migraine: A post hoc analysis of EVOLVE-1 and EVOLVE-2.
Headache. 2023 Nov 28. doi: 10.1111/head.14652. PubMedAbstract available
ASHINA M, Mitsikostas DD, Ramirez Campos V, Barash S, et al Numbers needed to treat or harm and likelihood of being helped versus harmed for
fremanezumab in patients who had prior inadequate response to two to four classes
of migraine preventive medications: A post hoc analysis.
Headache. 2023 Nov 13. doi: 10.1111/head.14651. PubMedAbstract available
WU J, Yang P, Wu X, Yu X, et al Association between secondhand smoke exposure and severe headaches or migraine in
never-smoking adults.
Headache. 2023 Nov 8. doi: 10.1111/head.14640. PubMedAbstract available
SZPERKA CL, Witzman S, Ostapenko S, Farrar JT, et al Patient headache questionnaires can improve headache diagnosis and treatment in
children.
Headache. 2023;63:1359-1371. PubMedAbstract available
IACONANGELO CJ, Serrano D, Adams AM, Trugman JM, et al Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc
exploratory analysis of the ACHIEVE I and ACHIEVE II trials.
Headache. 2023;63:1412-1422. PubMedAbstract available
HYERACI G, Paoletti O, Iannone LF, Gini R, et al Patterns of anti-CGRP mAbs use and variation of triptan consumption following
treatment initiation: A descriptive drug utilization study in the Tuscany region,
Italy.
Headache. 2023;63:1391-1402. PubMedAbstract available
MERLI E, Rustici A, Gramegna LL, Di Donato M, et al Vessel-wall MRI in primary headaches: The role of neurogenic inflammation.
Headache. 2023;63:1372-1379. PubMedAbstract available
October 2023
MOSKATEL LS, Graber-Naidich A, He Z, Zhang N, et al The introduction of the CGRP monoclonal antibodies and their effect on the
prescription patterns of chronic migraine preventive medications in a tertiary
headache center: A retrospective, observational analysis.
Headache. 2023 Oct 26. doi: 10.1111/head.14642. PubMedAbstract available
CHIANG CC Hypermobility spectrum disorders and migraine in adolescents.
Headache. 2023 Oct 24. doi: 10.1111/head.14650. PubMed
PORTT AE, Orchard C, Chen H, Ge E, et al Migraine and air pollution: A systematic review.
Headache. 2023 Oct 5. doi: 10.1111/head.14632. PubMedAbstract available
LIPTON RB, Pozo-Rosich P, Orr SL, Reed ML, et al Impact of monthly headache days on migraine-related quality of life: Results from
the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
Headache. 2023 Oct 5. doi: 10.1111/head.14629. PubMedAbstract available
MCCRACKEN HT, Lee AA, Smitherman TA Headache and psychological variables as predictors of disability in individuals
with primary headache disorders.
Headache. 2023;63:1259-1270. PubMedAbstract available
September 2023
MD ISA NA, Tummanapalli SS, Chiang JCB, Krishnan AV, et al Neuropathic changes in corneal nerve endings-A potential objective biomarker for
migraine frequency and response to treatment.
Headache. 2023 Sep 23. doi: 10.1111/head.14630. PubMed
WANG VS, Kosman J, Yuan H, Lauritsen C, et al Safety, tolerability, and effectiveness of repetitive intravenous
dihydroergotamine for refractory chronic migraine with cardiovascular risk
factors: A retrospective study.
Headache. 2023 Sep 23. doi: 10.1111/head.14636. PubMedAbstract available
KRUSE JA, Seng EK Changes in cognitive appraisal in a randomized controlled trial of
mindfulness-based cognitive therapy for patients with migraine.
Headache. 2023 Sep 18. doi: 10.1111/head.14627. PubMedAbstract available
SHAPIRO HFJ, Loder E, Shapiro DJ Association between clinician specialty and prescription of preventive medication
for young adults with migraine: A retrospective cohort study.
Headache. 2023 Sep 11. doi: 10.1111/head.14628. PubMedAbstract available
SILVA-NETO RP, Soares AA, Souza WPO, Krymchantowski AG, et al "Growing pains" in children and adolescents as an early symptom of migraine: A
prospective study.
Headache. 2023 Sep 6. doi: 10.1111/head.14608. PubMedAbstract available
CHARLES A Aura is a symptom of a migraine attack, not its cause.
Headache. 2023 Sep 4. doi: 10.1111/head.14623. PubMed
CLEMENTI MA, Kienzler C, Yonker M, Harmon M, et al Preliminary exploration of a multidimensional sleep health composite in
adolescent females with frequent migraine.
Headache. 2023 Sep 1. doi: 10.1111/head.14626. PubMedAbstract available
LIU H, Zhang S, Gong Z, Zhao W, et al Association between migraine and cardiovascular disease mortality: A prospective
population-based cohort study.
Headache. 2023 Sep 1. doi: 10.1111/head.14616. PubMedAbstract available
LEI X, Wei M, Wang L, Liu C, et al Resting-state electroencephalography microstate dynamics altered in patients with
migraine with and without aura-A pilot study.
Headache. 2023 Sep 1. doi: 10.1111/head.14622. PubMedAbstract available
TEPPER SJ, Schwedt TJ, Vo P, Thompson J, et al Healthcare costs and resource utilization in patients with migraine treated with
erenumab: A retrospective, non-interventional study using claims data from the
United States.
Headache. 2023 Sep 1. doi: 10.1111/head.14612. PubMedAbstract available
MACGREGOR EA, Hutchinson S, Lai H, Dabruzzo B, et al Safety and efficacy of ubrogepant for the acute treatment of perimenstrual
migraine attacks: A post hoc analysis.
Headache. 2023 Sep 1. doi: 10.1111/head.14619. PubMedAbstract available
Correction to "Regional cerebral perfusion during the premonitory phase of
triggered migraine: A double-blind randomized placebo-controlled functional
imaging study using pseudo-continuous arterial spin labelling".
Headache. 2023;63:1199. PubMed
MARTINDALE C, Presson AP, Schwedt TJ, Brennan KC, et al Sensory hypersensitivities are associated with post-traumatic headache-related
disability.
Headache. 2023;63:1061-1069. PubMedAbstract available
FILA M, Pawlowska E, Szczepanska J, Blasiak J, et al Autophagy may protect the brain against prolonged consequences of headache
attacks: A narrative/hypothesis review.
Headache. 2023;63:1154-1166. PubMedAbstract available
KATSUKI M, Matsumori Y, Kawamura S, Kashiwagi K, et al Developing an artificial intelligence-based diagnostic model of headaches from a
dataset of clinic patients' records.
Headache. 2023;63:1097-1108. PubMedAbstract available
August 2023
ZAMIR O, Yarns BC, Lagman-Bartolome AM, Jobanputra L, et al Understanding the gaps in headache and migraine treatment with psychological and
behavioral interventions: A narrative review.
Headache. 2023 Aug 28. doi: 10.1111/head.14624. PubMedAbstract available
POLK AN, Smitherman TA A meta-analytic review of acceptance-based interventions for migraine.
Headache. 2023 Aug 27. doi: 10.1111/head.14614. PubMedAbstract available
RICHER L, Luu H, Martins KJB, Vu K, et al Trajectory of health care resources among adults stopping or reducing treatment
frequency of botulinum toxin for chronic migraine treatment in Alberta, Canada.
Headache. 2023 Aug 23. doi: 10.1111/head.14613. PubMedAbstract available
MATSUMORI Y, Ishida M, Iba K, Kim BK, et al Improved quality of life with fremanezumab in Japanese and Korean patients with
episodic and chronic migraine: Results of two multicenter, randomized,
double-blind, placebo-controlled, parallel-group clinical trials.
Headache. 2023 Aug 21. doi: 10.1111/head.14606. PubMedAbstract available
KILINC YB, Kilinc E, Danis A, Hanci F, et al Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1alpha are elevated
in pediatric migraine attacks.
Headache. 2023 Aug 19. doi: 10.1111/head.14618. PubMedAbstract available
ORNELLO R, Bruno F, Frattale I, Curcio G, et al White matter hyperintensities in migraine are not mediated by a dysfunction of
the glymphatic system-A diffusion tensor imaging magnetic resonance imaging
study.
Headache. 2023 Aug 18. doi: 10.1111/head.14607. PubMedAbstract available
QIN Z, Qu H, Liang HB, Zhou Q, et al Altered resting-state effective connectivity of trigeminal vascular system in
migraine without aura: A spectral dynamic causal modeling study.
Headache. 2023 Aug 7. doi: 10.1111/head.14602. PubMedAbstract available
YANG L, Zhou Y, Zhang L, Wang Y, et al Aryl hydrocarbon receptors improve migraine-like pain behaviors in rats through
the regulation of regulatory T cell/T-helper 17 cell-related homeostasis.
Headache. 2023 Aug 4. doi: 10.1111/head.14599. PubMedAbstract available
July 2023
NAHMAN-AVERBUCH H, Callahan D, Darken R, Haroutounian S, et al Harnessing the conditioned pain modulation response in migraine diagnosis,
outcome prediction, and treatment-A narrative review.
Headache. 2023 Jul 31. doi: 10.1111/head.14601. PubMedAbstract available
GELFAND AA, Allen IE, Grimes B, Irwin S, et al Melatonin for migraine prevention in children and adolescents: A randomized,
double-blind, placebo-controlled trial after single-blind placebo lead-in.
Headache. 2023 Jul 19. doi: 10.1111/head.14600. PubMedAbstract available
MEHNERT J, Fischer-Schulte L, May A Aura phenomena do not initiate migraine attacks-Findings from neuroimaging.
Headache. 2023 Jul 14. doi: 10.1111/head.14597. PubMedAbstract available
DE VRIES LENTSCH S, Perenboom MJL, Carpay JA, MaassenVanDenBrink A, et al Visual hypersensitivity in patients treated with anti-calcitonin gene-related
peptide (receptor) monoclonal antibodies.
Headache. 2023;63:926-933. PubMedAbstract available
REIDY BL, Riddle EJ, Powers SW, Slater SK, et al Biopsychosocial treatment response among youth with continuous headache: A
retrospective, clinic-based study.
Headache. 2023;63:942-952. PubMedAbstract available
June 2023
LANE IA, Zempsky WT Capturing the experiences of sexual and gender minorities with migraine headache.
Headache. 2023 Jun 27. doi: 10.1111/head.14595. PubMed
JICHA CJ, Alex A, Herskovitz S, Haut SR, et al Migraine with prolonged aphasic aura associated with a CACNA1A mutation: A case
report and narrative review.
Headache. 2023 Jun 27. doi: 10.1111/head.14594. PubMedAbstract available
NAGRI A, Patel M, Mwansisya T, Adebayo PB, et al Development and initial validation of the Kiswahili version of the Migraine
Disability Assessment (MIDAS-K) questionnaire.
Headache. 2023 Jun 27. doi: 10.1111/head.14592. PubMedAbstract available
DANNO D, Ishizaki K, Kikui S, Takeshima T, et al Treatment of hemiplegic migraine with anti-calcitonin gene-related peptide
monoclonal antibodies: A case series in a tertiary-care headache center.
Headache. 2023 Jun 27. doi: 10.1111/head.14591. PubMedAbstract available
BOCZARSKA-JEDYNAK M, Blumenfeld AM Injection technique of the upper face with onabotulinumtoxinA in chronic
migraine.
Headache. 2023 Jun 27. doi: 10.1111/head.14588. PubMedAbstract available
PERETZ A, Stark-Inbar A, Harris D, Tamir S, et al Safety of remote electrical neuromodulation for acute migraine treatment in
pregnant women: A retrospective controlled survey-study.
Headache. 2023 Jun 19. doi: 10.1111/head.14586. PubMed
RODRIGUEZ-RIVAS R, Moreno-Martinez CA, Cerqueira TL, Enriquez-Peregrino KG, et al Translation, cross-cultural adaptation, and validation of a Latin American
Spanish version of the ID Migraine screening test.
Headache. 2023 Jun 16. doi: 10.1111/head.14509. PubMedAbstract available
MANGANO GD, Capizzi MR, Mantuano E, Veneziano L, et al Familial hemiplegic migraine in pediatric patients: A genetic, clinical, and
follow-up study.
Headache. 2023 Jun 16. doi: 10.1111/head.14582. PubMedAbstract available
COHEN F, Bobker S From diet to disasters, lifestyle factors can affect headaches and migraine.
Headache. 2023 Jun 15. doi: 10.1111/head.14500. PubMed
AHMED Z, Honomichl R, Thompson SF, Cohen JM, et al Clinical characteristics and patient-reported outcomes of chronic and episodic
migraine patients at a US tertiary headache center: A retrospective observational
study.
Headache. 2023 Jun 14. doi: 10.1111/head.14527. PubMedAbstract available
YU B, Hou S, Xing Y, Jia Z, et al Ultrasound-guided stellate ganglion block for the treatment of migraine in
elderly patients: A retrospective and observational study.
Headache. 2023 Jun 14. doi: 10.1111/head.14537. PubMedAbstract available
TEPPER SJ, Lipton RB, Silberstein SD, Kudrow D, et al Long-term efficacy and safety of erenumab in patients with chronic migraine and
acute medication overuse: A subgroup analysis.
Headache. 2023 Jun 14. doi: 10.1111/head.14536. PubMedAbstract available
SENG EK, Parker A, Shapiro RE, Buse DC, et al Living in society, living with migraine: Editorial for the 2022 Members' Choice
Award paper.
Headache. 2023 Jun 14. doi: 10.1111/head.14530. PubMed
ZLOOF Y, Simchoni M, Derazne E, Tsur AM, et al Hypermobility spectrum disorders and active migraine in Israeli adolescents: A
nationwide study.
Headache. 2023 Jun 14. doi: 10.1111/head.14526. PubMedAbstract available
ZHANG Y, Smith JH, Mullan AF, Vanmeter DE, et al Frequency of headache in emergency department patients with anaphylaxis: A
cross-sectional study.
Headache. 2023;63:834-838. PubMedAbstract available
KARSAN N, Bose RP, O'Daly O, Zelaya F, et al Regional cerebral perfusion during the premonitory phase of triggered migraine: A
double-blind randomized placebo-controlled functional imaging study using
pseudo-continuous arterial spin labeling.
Headache. 2023;63:771-787. PubMedAbstract available
PARK SY, Kim J Characteristics of patients who visited emergency departments for headache in
South Korea: A descriptive cross-sectional study.
Headache. 2023;63:795-804. PubMedAbstract available
May 2023
SACCA F, Braca S, Sansone M, Miele A, et al A head-to-head observational cohort study on the efficacy and safety of
monoclonal antibodies against calcitonin gene-related peptide for chronic and
episodic migraine.
Headache. 2023 May 31. doi: 10.1111/head.14528. PubMedAbstract available
LAU CI, Chen WH, Wang HC, Walsh V, et al Decision-making impairment under ambiguity but not under risk may underlie
medication overuse in patients with chronic migraine.
Headache. 2023 May 26. doi: 10.1111/head.14513. PubMedAbstract available
HANS A, Stonnington CM, Zhang N, Butterfield R, et al The impact of resilience on headache disability as measured by the Migraine
Disability Assessment (MIDAS).
Headache. 2023 May 23. doi: 10.1111/head.14518. PubMedAbstract available
LIPTON RB, Sico J, Seng EK Migraine screening in English and Spanish.
Headache. 2023 May 4. doi: 10.1111/head.14520. PubMed
MANGRUM R, Gerstein MT, Hall CJ 3rd, Buse DC, et al Priority acute and preventive migraine treatment benefits: Results of the
Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people
living with migraine.
Headache. 2023 May 4. doi: 10.1111/head.14521. PubMedAbstract available
KELLIER DJ, de Prado BM, Haagen D, Grabner P, et al Validity of self-reported migraine in adolescents and children.
Headache. 2023 May 4. doi: 10.1111/head.14498. PubMedAbstract available
TEPPER SJ, Dong Y, Vincent M, Wietecha LA, et al Sustained response of galcanezumab in migraine prevention: Patient-level data
from a post hoc analysis in patients with episodic or chronic migraine.
Headache. 2023 May 3. doi: 10.1111/head.14494. PubMedAbstract available
MEI HR, Hu YY, Kapadia S, Ouimet T, et al Efficacy of dual enkephalinase inhibition in a preclinical migraine model is
mediated by activation of peripheral delta opioid receptors.
Headache. 2023;63:621-633. PubMedAbstract available
ACKLEY E, Asamoah P, Mirsky D, White C, et al Dots and spots: A retrospective review of T2-hyperintense white matter lesions in
pediatric patients with and without headache.
Headache. 2023;63:611-620. PubMedAbstract available
HOULE TT, Smith MR, Turner DP Common challenges in the development of prediction models.
Headache. 2023;63:569-570. PubMed
KATSUKI M, Tatsumoto M, Kimoto K, Iiyama T, et al Investigating the effects of weather on headache occurrence using a smartphone
application and artificial intelligence: A retrospective observational
cross-sectional study.
Headache. 2023;63:585-600. PubMedAbstract available
April 2023
WANG Z, Lin Q, Peng YB Multi-region local field potential signatures and brain coherence alternations in
response to nitroglycerin-induced migraine attacks.
Headache. 2023 Apr 10. doi: 10.1111/head.14506. PubMedAbstract available
CHEN YJ, Hu KF, Chan C, Huang C, et al Association of periodontal disease with migraine: A large-scale community-based
cross-sectional study.
Headache. 2023 Apr 10. doi: 10.1111/head.14491. PubMedAbstract available
CARMILLO L, Fasano A Fremanezumab plus plasmapheresis in a patient with chronic migraine and
myasthenia gravis: Case report of an effective treatment.
Headache. 2023 Apr 10. doi: 10.1111/head.14497. PubMedAbstract available
THOMPSON AC, Goodbourn PT, Forte JD Perceived severity of Visual Snow Syndrome is associated with visual allodynia.
Headache. 2023;63:494-505. PubMedAbstract available
March 2023
OLIVEIRA FAA, Dourado-Filho MG, Sampaio Rocha-Filho PA Assessing the influence of migraine on ischemic penumbra and on the prognosis of
ischemic stroke: A prospective cohort study.
Headache. 2023 Mar 29. doi: 10.1111/head.14492. PubMedAbstract available
DIGRE KB Good New? Bad News? Idiopathic intracranial hypertension and migraine.
Headache. 2023 Mar 29. doi: 10.1111/head.14489. PubMed
GRAF M, Kim E, Brewer I, Hernandez J, et al Expert consensus established around flexible, individualized migraine treatment
utilizing a modified Delphi panel.
Headache. 2023 Mar 15. doi: 10.1111/head.14479. PubMedAbstract available
GERSTEIN MT, Wirth RJ, Uzumcu AA, Houts CR, et al Patient-reported experiences with migraine-related cognitive symptoms: Results of
the MiCOAS qualitative study.
Headache. 2023 Mar 10. doi: 10.1111/head.14484. PubMedAbstract available
VERHAGEN IE, van der Arend BWH, van Casteren DS, le Cessie S, et al Sex differences in migraine attack characteristics: A longitudinal E-diary study.
Headache. 2023;63:333-341. PubMedAbstract available
KUDROW D, Dafer R, Dodick DW, Starling A, et al Evaluation of vascular risk in patients with migraine with and without aura
treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
Headache. 2023;63:418-428. PubMedAbstract available
BASEDAU H, Oppermann T, Gundelwein Silva E, Peng KP, et al Characterization of trigeminal C-fiber reactivity through capsaicin-induced
release of calcitonin gene-related peptide.
Headache. 2023;63:353-359. PubMedAbstract available
ACKLEY E, Gibler RC, Orr SL, Powers SW, et al Virtual issue: Recent advances in pediatric headache: Bridging the data gap.
Headache. 2023;63:305-306. PubMed
February 2023
ESTAVE PM, Margol C, Beeghly S, Anderson R, et al Mechanisms of mindfulness in patients with migraine: Results of a qualitative
study.
Headache. 2023 Feb 28. doi: 10.1111/head.14481. PubMedAbstract available